Life Sciences Market

Access & Public Affairs

We know the processes and the people.

Our creative approach is bold and solutions oriented.

You have access to a team with an unmatched track record of success.

King Strategies is a boutique consulting firm focused on life sciences market access strategy, negotiation, and public affairs in Canada. Our proven approach accelerates adoption in provincial health systems and shapes policy in the health, medical, biotech, and environment sectors.

ELEVATE YOUR ENGAGEMENT

Our critical knowledge will help you navigate provincial governments in Canada and accomplish your objectives to professional pharmaceutical industry standards.

We understand the complexity of health delivery systems in each province, how decisions are made at federal, provincial, and municipal tables, and how to effectively engage them.

EXPAND YOUR FIELD CAPACITY

Ensure your message is heard through our comprehensive and well-researched government relations, stakeholder relations, and creative partnerships. 

We are your eyes and ears on the ground, seeking insights that affect your business. We make connections and connect the dots.

ENHANCE YOUR VISIBILITY

We align your message with the priorities of key decision makers, elevating your solution to today’s most pressing and urgent challenges.

Well-networked in provincial government ecosystems, we have the capabilities to inform your strategy, test it, and gain insights.

The King Strategies Team

Our innovative team has the critical knowledge and experience to help you understand and navigate the Canadian life sciences ecosystem and payor landscape. We have a proven and effective approach. With industry leading capability and experience, we’ll help you navigate an ever-shifting policy landscape and get your innovation to Canadians sooner.  

We provide political insight, as well as make on-the-ground connections. Our hands-on approach means you will receive exemplary project management, logistical support, and ongoing analysis of the life sciences landscape.

  • Kim King is a determined, passionate leader who brought a high degree of expertise and influence to a challenging position. She thrives in a dynamic environment, and could be counted on to take on any hurdle, big or small, and see it through to completion. This commitment has served Kim well, and will no doubt add value to her current clients and endeavours.

    Roman Cooney, HammerCo Communications

  • Kim King’s ability to work on behalf of patients with payers and governments has led to many patients getting the medicines they deserve. An exceptional health policy and patient access leader! Additionally her positive attitude, collaborative spirit and transparent communication style makes her an asset on any team.

    Jeff Martens, Vice President of Global Communications at Knight Therapeutics. Inc.

  • We have been privileged at Novartis Canada to benefit from Kim's health ecosystem knowledge and strong relationships across western Canada. Kim effectively accelerated our business goals through bold approaches and effective advocacy. Kim's talents were perhaps best demonstrated through strategic partnerships and the launch of Canada's first gene therapies. She is an effective market access and government relations professional whose energy, positivity, and creativity would be an asset to any organization.

    Andrea Marazzi, President Novartis Canada

  • As a Director of the Royal Alexandra Hospital Foundation, Kim had been an active volunteer on our Eye Institute of Alberta campaign and was the Chair of the Communications and External Relations Committee. An outstanding supporter of our hospital and leader for our foundation.

    Andrew Otway, Otway Advisory Services

  • I had the great pleasure of serving on the Board of Directors of the Association for Mountain Parks Protection and Enjoyment (AMPPE) during Kim’s time as Executive Director. Her skills at GR as well as stakeholder relations were extremely impressive. A strong administrator who can effectively, efficiently and convincingly relay information to her board, team or shareholders. Happy to be one of the many who would endorse her without hesitation.

    David McKenna, Chief Executive Officer, Rocky Mountaineer

  • During my time at Novartis, I worked with Kimberly on patient access and on government relations. We tackled many issues arising from changes in the industry and in the healthcare environment. Kimberly was always extremely well informed and was able to develop solid plans to help advance patient access to medicines while working collaboratively with all stakeholders. She is a positive and energetic individual who gets things done and she's a pleasure to work with.

    Janice Murray, CPA, ICD.D,